Request Sample Inquiry
Diabetic Macular Edema Market

Diabetic Macular Edema Market

Diabetic Macular Edema Market Global Industry Assessment & Forecast

img
Healthcare
# Pages:

145

Base Year:

2021

Nov - 2021

Format:

Report Code:

VMR-2021-0525

Segments Covered
  • By Indication Type, diffuse diabetic macular edema, focal diabetic macular edema
  • By Treatment Type anti-VEGF, corticosteroids, laser photocoagulation therapy, other off-label drugs
  • By End User hospitals, clinics, home care
Snapshot
Forecast YearsForecast Years: 2021 - 2028
Historical YearsHistorical Years: 2016 - 2020
Revenue 2021Revenue 2021: 3.7 Billion
Revenue 2028Revenue 2028: 4.74 Billion
Revenue CAGRRevenue CAGR (2021 - 2028): 3.15
Fastest Growing Region Fastest Growing Region (2022 - 2028) North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report
  • Go To Market Strategy
  • Region Specific Market Dynamics
  • Region Level Market Share
  • Import Export Analysis
  • Production Analysis
  • Others Request Customization Speak To Analyst

Table of Content:

  1. Chapter No. 1: Introduction
    1. Report Scope
    2. Objectives of the Study
    3. USP & Key Offerings
    4. Target Audience
    5. Vantage Market Research Report Guidance/Walk-through
  2. Chapter No. 2: Premium Insights
    1. Market Snapshot
    2. Top Investment Pockets
      1. Market Attractiveness Analysis, By Indication Type,
      2. Market Attractiveness Analysis, By Treatment Type
      3. Market Attractiveness Analysis, By End User
      4. Market Attractiveness Analysis, By North America
    3. Insights from Primary Respondents
  3. Chapter No. 3: Key Market Dynamics
    1. Introduction
    2. Market Drivers
    3. Market Restraints
    4. Market Opportunities
    5. Porter’s Five Forces Analysis
    6. PEST Analysis
    7. Regulatory Landscape
    8. Technology Landscape
    9. Regional Market Trends
    10. Pricing Analysis
    11. Patent Analysis
    12. Value Chain Analysis
    13. Downstream Buyers
    14. Distributors/Traders List
  4. Chapter No. 4: Competitive Landscape
    1. Competition Matrix – 2020
    2. Company Market Share Analysis – 2020
      1. Company Market Share, 2020
      2. Company Market Revenue, 2017 – 2020 (USD Million)
      3. Company Y-o-Y Growth, 2018 – 2020 (%)
    3. Strategic Developments
      1. CAcquisitions & Mergers
      2. New Product Launch
      3. New Product Launch
    4. New Product Launch
  5. Chapter No. 5: COVID 19 Impact Analysis
    1. Impact Assessment of COVID-19 Pandemic, By North America
      1. North America
      2. Europe
      3. Asia Pacific
      4. Latin America
      5. Middle East & Africa
    2. Quarterly Market Revenue Forecast by North America 2020 & 2021
    3. Pre COVID-19 Market Revenue, By North America, 2016-2019 (USD Million)
    4. Post COVID-19 Market Revenue, By North America, 2020-2028 (USD Million)
    5. Key Strategies Undertaken by Companies to Tackle COVID-19
    6. Short Term Dynamics
    7. Long Term Dynamics
  6. Chapter No. 6: Global Diabetic Macular Edema Market - Segment Analysis
    1. Overview
    2. Global Diabetic Macular Edema Market, 2016 – 2028 (USD Million)
      1. Global Market Revenue, By North America, 2020 & 2028
    3. Global Market Revenue, By North America, 2020 & 2028
      1. Global Market Revenue, By North America, 2020 & 2028
    4. Global Keyword Market - By Treatment Type
      1. Overview
    5. Global Keyword Market - By End User
      1. Overview
    6. Global Keyword Market - By North America
      1. Overview
      2. Global Market Revenue, By North America, 2016 – 2028 (USD Million)
  7. Chapter No. 7: North America Diabetic Macular Edema Market - Segment Analysis
    1. Overview
    2. North America Diabetic Macular Edema Market, 2016 – 2028 (USD Million)
    3. North America Market, By Indication Type,
      1. North America Market Revenue, By Indication Type,, 2016 – 2028
    4. North America Market, By Treatment Type
      1. North America Market Revenue, By Treatment Type, 2016 – 2028
    5. North America Market, By End User
      1. North America Market Revenue, By End User, 2016 – 2028
    6. North America Market, By
      1. North America Market Revenue, By , 2016 – 2028 (USD Million)
  8. Chapter No. 8: Europe Diabetic Macular Edema Market - Segment Analysis
    1. Overview
    2. Europe Diabetic Macular Edema Market, 2016 – 2028 (USD Million)
      1. Europe Market Revenue Share, By , 2020 & 2028
    3. Europe Market, By Indication Type,
      1. Europe Market Revenue, By Indication Type,, 2016 – 2028
    4. Europe Market, By Treatment Type
      1. Europe Market Revenue, By Treatment Type, 2016 – 2028
    5. Europe Market, By End User
      1. Europe Market Revenue, By End User, 2016 – 2028
    6. Europe Market, By
      1. Europe Market Revenue, By , 2016 – 2028 (USD Million)
  9. Chapter No. 9: Asia Pacific Diabetic Macular Edema Market - Segment Analysis
    1. Overview
    2. Asia Pacific Diabetic Macular Edema Market, 2016 – 2028 (USD Million)
      1. Asia Pacific Market Revenue Share, By , 2020 & 2028
    3. Asia Pacific Market, By Indication Type,
      1. Asia Pacific Market Revenue, By Indication Type,, 2016 – 2028
    4. Asia Pacific Market, By Treatment Type
      1. Asia Pacific Market Revenue, By Treatment Type, 2016 – 2028
    5. Asia Pacific Market, By End User
      1. Asia Pacific Market Revenue, By End User, 2016 – 2028
    6. Asia Pacific Market, By
      1. Asia Pacific Market Revenue, By , 2016 – 2028 (USD Million)
  10. Chapter No. 10: Latin America Diabetic Macular Edema Market - Segment Analysis
    1. Overview
    2. Latin America Diabetic Macular Edema Market, 2016 – 2028 (USD Million)
      1. Latin America Market Revenue Share, By , 2020 & 2028
    3. Latin America Market, By Indication Type,
      1. Latin America Market Revenue, By Indication Type,, 2016 – 2028
    4. Latin America Market, By Treatment Type
      1. Latin America Market Revenue, By Treatment Type, 2016 – 2028
    5. Latin America Market, By End User
      1. Latin America Market Revenue, By End User, 2016 – 2028
    6. Latin America Market, By
      1. Latin America Market Revenue, By , 2016 – 2028 (USD Million)
  11. Chapter No. 11: Middle East & Africa Diabetic Macular Edema Market - Segment Analysis
    1. Overview
    2. Middle East & Africa Diabetic Macular Edema Market, 2016 – 2028 (USD Million)
      1. Middle East & Africa Market Revenue Share, By , 2020 & 2028
    3. Middle East & Africa Market, By Indication Type,
      1. Middle East & Africa Market Revenue, By Indication Type,, 2016 – 2028
    4. Middle East & Africa Market, By Treatment Type
      1. Middle East & Africa Market Revenue, By Treatment Type, 2016 – 2028
    5. Middle East & Africa Market, By End User
      1. Middle East & Africa Market Revenue, By End User, 2016 – 2028
    6. Middle East & Africa Market, By
      1. Middle East & Africa Market Revenue, By , 2016 – 2028 (USD Million)
  12. Chapter No. 12: Marketing Strategy Analysis
    1. Marketing Channel
    2. Direct Marketing
    3. Indirect Marketing
    4. Marketing Channel Development Trends
    5. Economic/Political Environmental Change
  13. Chapter No. 13: Company Profiles
    1. Company
  14. Chapter No. 14: Research Methodology
    1. Research Methodology
    2. Phase I - Secondary Research
    3. Phase II - Data Modeling
      1. Company Share Analysis Model
      2. Revenue Based Modeling
    4. Phase III - Primary Research
    5. Research Limitations
      1. Research Limitations
FAQ
Frequently Asked Question

  • The global Diabetic Macular Edema valued at 3.7 Billion in 2020 and is expected to reach 4.74 Billion in 2028 growing at a CAGR of 3.15%.

  • The prominent players in the market are Pfizer Inc., Bayer AG, Bausch & Lomb Incorporated, Allergan Inc., F. Hoffmann-La Roche Ltd., Regeneron Pharmaceuticals Inc., ShahidBeheshti University of Medical Sciences., Johns Hopkins University, Novartis AG, The National Eye Institute..

  • The market is project to grow at a CAGR of 3.15% between 2021 and 2028.

  • The driving factors of the Diabetic Macular Edema include

    • The increasing research & development activities for the treatment of diabetic macular edema is likely to accelerate the growth of the diabetic macular edema treatment market during the forecast period.
    • Additionally, advancements in ophthalmic surgery techniques and R&D investment by pharmaceutical companies is further expected to boost the growth of the market in the years to come.

  • North America was the leading regional segment of the Diabetic Macular Edema in 2020.

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies Privacy Policy